Compare · ALGN vs NTRB
ALGN vs NTRB
Side-by-side comparison of Align Technology Inc. (ALGN) and Nutriband Inc. (NTRB): market cap, price performance, sector, and recent activity on the wire.
Summary
- Both ALGN and NTRB operate in Industrial Specialties (Health Care), so they compete in similar markets.
- ALGN is the larger of the two at $10.61B, about 139.2x NTRB ($76.2M).
- Over the past year, ALGN is up 9.2% and NTRB is down 14.5% - ALGN leads by 23.7 points.
- ALGN has been more active in the news (5 items in the past 4 weeks vs 4 for NTRB).
- ALGN has more recent analyst coverage (25 ratings vs 1 for NTRB).
- Company
- Align Technology Inc.
- Nutriband Inc.
- Price
- $147.35-1.35%
- $6.21-1.58%
- Market cap
- $10.61B
- $76.2M
- 1M return
- -1.66%
- -17.26%
- 1Y return
- +9.20%
- -14.46%
- Industry
- Industrial Specialties
- Industrial Specialties
- Exchange
- NASDAQ
- NASDAQ
- IPO
- 2001
- News (4w)
- 5
- 4
- Recent ratings
- 25
- 1
Align Technology Inc.
Align Technology, Inc., a medical device company, designs, manufactures, and markets Invisalign clear aligners and iTero intraoral scanners and services for orthodontists and general practitioner dentists, and restorative and aesthetic dentistry. It operates in two segments, Clear Aligner; and Scanners and Services. The Clear Aligner segment consists of comprehensive products, including Invisalign comprehensive treatment that addresses the orthodontic needs of teenage patients, such as mandibular advancement, compliance indicators, and compensation for tooth eruption; and Invisalign First Phase I and Invisalign First Comprehensive Phase 2 package for younger patients generally between the ages of seven and ten years, which is a mixture of primary/baby and permanent teeth. This segment's non-comprehensive products comprise Invisalign moderate, lite and express packages, and Invisalign go; and non-case products include retention products, Invisalign training fees, and sales of ancillary products, such as cleaning material, and adjusting tools used by dental professionals during the course of treatment. The Scanners and Services segment offers iTero scanner, a single hardware platform with software options for restorative or orthodontic procedures; restorative software for general practitioner dentists, prosthodontists, periodontists, and oral surgeons; and software for orthodontists for digital records storage, orthodontic diagnosis, and for the fabrication of printed models and retainers. This segment also provides computer-aided design and computer-aided manufacturing services; ancillary products, such as disposable sleeves for the wand; iTero model and dies; third party scanners and digital scans; Invisalign outcome simulator, a chair-side and cloud-based application for the iTero scanner; Invisalign progress assessment tool; and TimeLapse technology, which allows doctors or practitioners to compare a patient's historic 3D scans to the present-day scan. The company sells its products in the United States, Switzerland, China, and internationally. Align Technology, Inc. was incorporated in 1997 and is headquartered in Tempe, Arizona.
Nutriband Inc.
Nutriband Inc. develops a portfolio of transdermal pharmaceutical products. The company's lead product in development is abuse deterrent fentanyl transdermal system that provides clinicians and patients with an extended-release transdermal fentanyl product for use in managing chronic pain. The company has a license agreement with Rambam Med-Tech Ltd. for the development of the RAMBAM Closed System Transfer Devices. Nutriband Inc. was incorporated in 2016 and is headquartered in Orlando, Florida.
Latest ALGN
- Align Technology Wins Significant Patent Infringement Case Against Angelalign at Unified Patent Court
- Align Tech downgraded by Robert W. Baird with a new price target
- Align Tech downgraded by Evercore ISI with a new price target
- Align Technology to Announce Third Quarter 2026 Results on October 28, 2026
- Align Technology Launches “SHIFT Happens” U.S. Campaign to Educate Adults About Lifelong Tooth Movement
- Align Technology to Speak at Upcoming Financial Conference
- SEC Form 4 filed by Director Blackford Quentin S.
- SEC Form 3 filed by new insider Blackford Quentin S.
- Align Technology Inc. filed SEC Form 8-K: Leadership Update, Financial Statements and Exhibits
- Quentin Blackford to Join Align Technology Board of Directors
Latest NTRB
- Nutriband Inc. announces exercise of warrants at $6.43 for Gross Proceeds of $1,753,274
- Nutriband Files New Patent Application to Strengthen Intellectual Property Protection of Its Transdermal Abuse Deterrent Technology
- Nutriband Marks Five Years on Nasdaq – CEO Letter to Shareholders
- SEC Form 25-NSE filed by Nutriband Inc.
- Nutriband Appoints Decorated Navy SEAL and Veterans Health Advocate Robert J. O'Neill to Advisory Board
- Nutriband Inc. filed SEC Form 8-K: Regulation FD Disclosure, Financial Statements and Exhibits
- Nutriband Confirms Warrants Will Expire September 30 Without Extension or Repricing
- Nutriband CEO, Gareth Sheridan to Attend the Nasdaq Life Sciences Advisory Board (LaB) Biotech Summit
- Nutriband Receives USPTO Notice of Publication of Commercial Brand Name Trademarks for Its Abuse Deterrent Fentanyl Patch
- Nutriband CEO, Gareth Sheridan to Present at the 2026 Georgia Life Sciences Summit as Part of the CEO Spotlight